» Visit www.biopharminternational.com to utilize our upgraded search engine, view expanded topic coverage, experience multimedia content, access content archives, and more.

BIOPHARM INTERNATIONAL 2010 WEBCAST SERIES
BioPharm International is pleased to present its 2010 Web Seminar Series, addressing key issues in process development and bioprocessing. These one-hour sessions include presentations by industry experts and interactive dialogue with the audience. Watch live and participate in the Q&A, or catch them later on demand.

Addressing the Challenges of Downstream Processing, Today and Tomorrow
Tuesday, September 21, 2010 at 11:00 AM ET
As upstream titers continue to improve, companies need solutions to ensure that cell culture gains are not lost in a downstream bottleneck. This web seminar will share data on new strategies and disruptive technologies that can streamline current processes and facilitate productivity, as well as improvements in traditional unit operations.

Characterizing Protein Products: Critical Questions and New Technologies
Thursday, November 11, 2010 at 11:00 AM ET
Protein characterization has always been critical for setting product specifications, determining process controls and release tests, and for establishing comparability after scale-up or site changes. Today, the analysis of protein structure has become even more important, given its key role in the debate over what constitutes "similarity" for biosimilar molecules. This seminar will analyze accepted and emerging methods for protein characterization, including the strengths and weaknesses of the methods and their use in regulatory filings.

Trastuzumab Glycan Batch-to-Batch Profiling using a UPLC/FLR/MS Platform
AUTHORS: Ying Qing Yu, Joomi Ahn, and Martin Gilar, Waters Corporation
Waters ACQUITY UPLC technology with detection by FLR and time-of-flight MS comprise a powerful solution for producing analytical data for batch-to-batch glycan profiling of a recombinant mAb, Trastuzumab. The resolution, reproducibility, and sensitivity enable glycoprofiling of therapeutic antibodies.

Managing Biomanufacturing Complexity: A complex systems approach
Biomanufacturing professionals face almost overwhelming complexity. Using Bio-G's software, services and proven processes we've helped clients find bottlenecks, increase throughput, lower risk, and accurately understand outcomes that can be expected from process changes. In this white paper you'll learn:
Why variability has such an impact on the manufacturing process
How to anticipate and deal with manufacturing problems
How to see through the reams of manufacturing data and find the real information you need